Supernus Pharmaceuticals
SUPN
SUPN
288 hedge funds and large institutions have $2.6B invested in Supernus Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 113 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
288
Holders Change
-32
Holders Change %
-10%
% of All Funds
6.59%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.05%
New
30
Increased
95
Reduced
113
Closed
60
Calls
$13M
Puts
$18.2M
Net Calls
-$5.24M
Net Calls Change
+$11.3M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$119M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$28.6M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
$50M |
| 4 |
BlackRock
New York
|
$403M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$16.3M |
